Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2003 Jun;88(6):536–539. doi: 10.1136/adc.88.6.536

Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries?

T Duke 1, A Michael 1, D Mokela 1, T Wal 1, J Reeder 1
PMCID: PMC1763115  PMID: 12765927

Abstract

Aims: To determine in children with meningitis whether there is any difference in mortality and neurological sequelae using chloramphenicol as first line treatment, with a change to ceftriaxone if chloramphenicol resistance is shown in vitro, compared to using ceftriaxone as first line treatment, with a change to chloramphenicol if there is no evidence of in vitro resistance.

Methods: An observational study with a retrospective control group nested within a randomised trial of fluid management for bacterial meningitis where clinical care was standardised. Chloramphenicol is standard treatment for bacterial meningitis in Papua New Guinea. In the first 150 cases we used chloramphenicol and only changed treatment to ceftriaxone if chloramphenicol resistance for cerebrospinal fluid isolates was proved. After finding 20% of Haemophilus influenzae were resistant to chloramphenicol, and that most affected children had poor outcomes, we changed to an alternative strategy. In the next 196 cases first line treatment was ceftriaxone and treatment was changed to chloramphenicol if the isolated bacteria were found to be susceptible.

Results: When chloramphenicol was used as first line treatment for meningitis followed by ceftriaxone when in vitro resistance was shown, there was invariably a very poor outcome in chloramphenicol resistant disease (71% of children died or had severe neurological complications). Using ceftriaxone as first line treatment was effective in reducing mortality and neurological sequelae from chloramphenicol resistant Haemophilus influenzae type (71% v 9%, relative risk 0.13; 95% CI 0.02 to 0.87; p = 0.013). Changing to chloramphenicol if there was no evidence of in vitro resistance was less than half the cost of empirical use of ceftriaxone for a full course for all children with meningitis.

Conclusions: Using a third generation cephalosporin as first line treatment is effective in dealing with the problem of poor outcomes from meningitis due to Haemophilus influenzae that is resistant to chloramphenicol, and a strategy of changing to chloramphenicol if in vitro susceptibility is shown will reduce the use of expensive third generation cephalosporins without comprising on clinical outcomes. This highlights the urgent need to reduce the costs of third generation cephalosporins, to improve bacteriological services in developing countries, and to introduce effective and affordable vaccines against H influenzae and Streptococcus pneumoniae.

Full Text

The Full Text of this article is available as a PDF (107.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronoff S. C., Reed M. D., O'Brien C. A., Blumer J. L. Comparison of the efficacy and safety of ceftriaxone to ampicillin/chloramphenicol in the treatment of childhood meningitis. J Antimicrob Chemother. 1984 Feb;13(2):143–151. doi: 10.1093/jac/13.2.143. [DOI] [PubMed] [Google Scholar]
  2. Baraff L. J., Lee S. I., Schriger D. L. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J. 1993 May;12(5):389–394. doi: 10.1097/00006454-199305000-00008. [DOI] [PubMed] [Google Scholar]
  3. Barson W. J., Miller M. A., Brady M. T., Powell D. A. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children. Pediatr Infect Dis. 1985 Jul-Aug;4(4):362–368. doi: 10.1097/00006454-198507000-00006. [DOI] [PubMed] [Google Scholar]
  4. Bryan J. P., Rocha H., da Silva H. R., Taveres A., Sande M. A., Scheld W. M. Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis. Antimicrob Agents Chemother. 1985 Sep;28(3):361–368. doi: 10.1128/aac.28.3.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Congeni B. L. Comparison of ceftriaxone and traditional therapy of bacterial meningitis. Antimicrob Agents Chemother. 1984 Jan;25(1):40–44. doi: 10.1128/aac.25.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Duke T. Antibiotic-resistant bacterial sepsis in Papua New Guinea. P N G Med J. 2000 Mar-Jun;43(1-2):82–90. [PubMed] [Google Scholar]
  7. Duke T., Michael A. Increase in sepsis due to multi-resistant enteric gram-negative bacilli in Papua New Guinea. Lancet. 1999 Jun 26;353(9171):2210–2211. doi: 10.1016/S0140-6736(99)02389-2. [DOI] [PubMed] [Google Scholar]
  8. Duke Trevor, Mokela David, Frank Dale, Michael Audrey, Paulo Theresa, Mgone Joyce, Kurubi Jonah. Management of meningitis in children with oral fluid restriction or intravenous fluid at maintenance volumes: a randomised trial. Ann Trop Paediatr. 2002 Jun;22(2):145–157. doi: 10.1179/027249302125000878. [DOI] [PubMed] [Google Scholar]
  9. Friedland I. R., Klugman K. P. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child. 1992 Aug;146(8):920–923. doi: 10.1001/archpedi.1992.02160200042023. [DOI] [PubMed] [Google Scholar]
  10. Friedland I. R., Klugman K. P. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet. 1992 Feb 15;339(8790):405–408. doi: 10.1016/0140-6736(92)90087-j. [DOI] [PubMed] [Google Scholar]
  11. Girgis N. I., Abu el Ella A. H., Farid Z., Haberberger R. L., Galal F. S., Woody J. N. Intramuscular ceftriaxone versus ampicillin-chloramphenicol in childhood bacterial meningitis. Scand J Infect Dis. 1988;20(6):613–617. doi: 10.3109/00365548809035661. [DOI] [PubMed] [Google Scholar]
  12. Gratten M., Naraqi S., Hansman D. High prevalence of penicillin-insensitive pneumococci in Port Moresby, Papua New Guinea. Lancet. 1980 Jul 26;2(8187):192–195. doi: 10.1016/s0140-6736(80)90072-0. [DOI] [PubMed] [Google Scholar]
  13. Haffejee I. E. Cefotaxime versus penicillin-chloramphenicol in purulent meningitis: a controlled single-blind clinical trial. Ann Trop Paediatr. 1988 Dec;8(4):225–229. doi: 10.1080/02724936.1988.11748576. [DOI] [PubMed] [Google Scholar]
  14. Jacobs R. F., Wells T. G., Steele R. W., Yamauchi T. A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children. J Pediatr. 1985 Jul;107(1):129–133. doi: 10.1016/s0022-3476(85)80634-x. [DOI] [PubMed] [Google Scholar]
  15. Klugman K. P., Madhi S. A. Emergence of drug resistance. Impact on bacterial meningitis. Infect Dis Clin North Am. 1999 Sep;13(3):637-46, vii. doi: 10.1016/s0891-5520(05)70098-2. [DOI] [PubMed] [Google Scholar]
  16. Molyneux E. M., Walsh A. L., Forsyth H., Tembo M., Mwenechanya J., Kayira K., Bwanaisa L., Njobvu A., Rogerson S., Malenga G. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002 Jul 20;360(9328):211–218. doi: 10.1016/s0140-6736(02)09458-8. [DOI] [PubMed] [Google Scholar]
  17. Moosa A. A., Quortum H. A., Ibrahim M. D. Rapid diagnosis of bacterial meningitis with reagent strips. Lancet. 1995 May 20;345(8960):1290–1291. doi: 10.1016/s0140-6736(95)90931-1. [DOI] [PubMed] [Google Scholar]
  18. Mulholland K., Hilton S., Adegbola R., Usen S., Oparaugo A., Omosigho C., Weber M., Palmer A., Schneider G., Jobe K. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet. 1997 Apr 26;349(9060):1191–1197. doi: 10.1016/s0140-6736(96)09267-7. [DOI] [PubMed] [Google Scholar]
  19. Ngu J., Youmbissi T. A comparative study with ceftriaxone (Rocephin) versus ampicillin and chloramphenicol in children with bacterial meningitis. Chemioterapia. 1987 Jun;6(2 Suppl):417–418. [PubMed] [Google Scholar]
  20. Odio C. M., Faingezicht I., Salas J. L., Guevara J., Mohs E., McCracken G. H., Jr Cefotaxime vs. conventional therapy for the treatment of bacterial meningitis of infants and children. Pediatr Infect Dis. 1986 Jul-Aug;5(4):402–407. doi: 10.1097/00006454-198607000-00005. [DOI] [PubMed] [Google Scholar]
  21. Peltola H., Anttila M., Renkonen O. V. Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group. Lancet. 1989 Jun 10;1(8650):1281–1287. doi: 10.1016/s0140-6736(89)92685-8. [DOI] [PubMed] [Google Scholar]
  22. Rodriguez W. J., Puig J. R., Khan W. N., Feris J., Gold B. G., Sturla C. Ceftazidime vs. standard therapy for pediatric meningitis: therapeutic, pharmacologic and epidemiologic observations. Pediatr Infect Dis. 1986 Jul-Aug;5(4):408–415. doi: 10.1097/00006454-198607000-00006. [DOI] [PubMed] [Google Scholar]
  23. Sharma P. R., Adhikari R. K., Joshi M. P., Lal M., Chodon T., Pokhrel B. M., Shrestha R. S., Shrestha I. B. Intravenous chloramphenicol plus penicillin versus intramuscular ceftriaxone for the treatment of pyogenic meningitis in Nepalese children. Trop Doct. 1996 Apr;26(2):84–85. doi: 10.1177/004947559602600215. [DOI] [PubMed] [Google Scholar]
  24. Steele R. W., Bradsher R. W. Comparison of ceftriaxone with standard therapy for bacterial meningitis. J Pediatr. 1983 Jul;103(1):138–141. doi: 10.1016/s0022-3476(83)80801-4. [DOI] [PubMed] [Google Scholar]
  25. Wells T. G., Trang J. M., Brown A. L., Marmer B. C., Jacobs R. F. Cefotaxime therapy of bacterial meningitis in children. J Antimicrob Chemother. 1984 Sep;14 (Suppl B):181–189. doi: 10.1093/jac/14.suppl_b.181. [DOI] [PubMed] [Google Scholar]
  26. del Rio M. A., Chrane D., Shelton S., McCracken G. H., Jr, Nelson J. D. Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet. 1983 Jun 4;1(8336):1241–1244. doi: 10.1016/s0140-6736(83)92696-x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES